Literature DB >> 9014206

Differentiation, differentiation/gene therapy and cancer.

R E Scott1.   

Abstract

"Differentiation, Differentiation/Gene Therapy and Cancer" is intended to suggest that an understanding of the cell and molecular biology of cell differentiation should advance the development of new cancer therapies. This article, therefore, reviews four general topics and their relationship to each other: (1) the multistep process of cell differentiation in nontransformed and transformed cells, (2) the use of drugs that induce differentiation in vitro as potential clinical differentiation therapy agents for cancer, (3) the evolving emphasis on gene therapy as a new cancer therapy modality, and (4) the concept of differentiation/gene therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9014206     DOI: 10.1016/s0163-7258(96)00120-9

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  12 in total

1.  Therapeutic Implications of PPARgamma in Human Osteosarcoma.

Authors:  Eric R Wagner; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Wenli Zhang; Qiong Shi; Qing Luo; Xiaoji Luo; Bo Liu; Jinyong Luo; Farbod Rastegar; Connie J He; Yawen Hu; Barrett Boody; Hue H Luu; Tong-Chuan He; Zhong-Liang Deng; Rex C Haydon
Journal:  PPAR Res       Date:  2010-02-16       Impact factor: 4.964

2.  Glycogen synthase kinase-3beta regulates astrocytic differentiation of U87-MG human glioblastoma cells.

Authors:  Yan Li; Hui-min Lu; Gang Li; Guang-mei Yan
Journal:  Acta Pharmacol Sin       Date:  2010-02-15       Impact factor: 6.150

3.  The Current and Future Therapies for Human Osteosarcoma.

Authors:  Joseph D Lamplot; Sahitya Denduluri; Jiaqiang Qin; Ruidong Li; Xing Liu; Hongyu Zhang; Xiang Chen; Ning Wang; Abdullah Pratt; Wei Shui; Xiaoji Luo; Guoxin Nan; Zhong-Liang Deng; Jinyong Luo; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Curr Cancer Ther Rev       Date:  2013-02

4.  NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism.

Authors:  Raquel Sitcheran; Patricia C Cogswell; Albert S Baldwin
Journal:  Genes Dev       Date:  2003-10-01       Impact factor: 11.361

5.  Defective osteogenic differentiation in the development of osteosarcoma.

Authors:  Eric R Wagner; Gaurav Luther; Gaohui Zhu; Qing Luo; Qiong Shi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Yanhong Gao; Ke Yang; Linyuan Wang; Chad Teven; Xiaoji Luo; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Yang Bi; Bai-Cheng He; Ni Tang; Jinyong Luo; Liang Chen; Guowei Zuo; Richard Rames; Rex C Haydon; Hue H Luu; Tong-Chuan He
Journal:  Sarcoma       Date:  2011-02-22

6.  LY294002 induces differentiation and inhibits invasion of glioblastoma cells by targeting GSK-3beta and MMP.

Authors:  Qi Tian; Hualei Cui; Yan Li; Huimin Lu
Journal:  EXCLI J       Date:  2012-02-27       Impact factor: 4.068

7.  Changes of nuclear matrix proteins following the differentiation of human osteosarcoma MG-63 cells.

Authors:  Chun-Hong Zhao; Qi-Fu Li; Yan Zhao; Jing-Wen Niu; Zhi-Xing Li; Jin-An Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2006-02       Impact factor: 7.691

Review 8.  Hepatocellular Carcinoma Differentiation: Research Progress in Mechanism and Treatment.

Authors:  Jianning Song; Hongzhong Zhou; Dayong Gu; Yong Xu
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

9.  Sodium valproate inhibits the growth of human cholangiocarcinoma in vitro and in vivo.

Authors:  Bing Wang; Rui Yang; Yue Wu; Hongbo Li; Zouxiao Hu; Yongjun Chen; Shengquan Zou
Journal:  Gastroenterol Res Pract       Date:  2013-11-13       Impact factor: 2.260

10.  Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells.

Authors:  Wenjie Zhou; Xiaoxun Chen; Ke He; Jinfeng Xiao; Xiaopeng Duan; Rui Huang; Zhenglin Xia; Jingliang He; Jinqian Zhang; Guoan Xiang
Journal:  Oncol Rep       Date:  2016-02-25       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.